These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 7529995)

  • 1. Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond.
    Zarnt T; Lang K; Burtscher H; Fischer G
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):159-64. PubMed ID: 7529995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth.
    Iwabuchi T; Maruyama T; Sei Y; Adachi K
    J Dermatol Sci; 1995 Jan; 9(1):64-9. PubMed ID: 7537082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
    Salowe SP; Hermes JD
    Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
    Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
    Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin.
    Cunningham EB
    Biochem Biophys Res Commun; 1995 Oct; 215(1):212-8. PubMed ID: 7575593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK-506-binding proteins from streptomycetes producing immunosuppressive macrolactones of the FK-506 type.
    Pahl A; Keller U
    J Bacteriol; 1992 Sep; 174(18):5888-94. PubMed ID: 1381710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte chemotactic activity of FKBP and inhibition by FK506.
    Leiva MC; Lyttle CR
    Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin.
    Maki N; Sekiguchi F; Nishimaki J; Miwa K; Hayano T; Takahashi N; Suzuki M
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5440-3. PubMed ID: 1695378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.
    Göthel SF; Marahiel MA
    Cell Mol Life Sci; 1999 Mar; 55(3):423-36. PubMed ID: 10228556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH titration of the histidine residues of cyclophilin and FK506 binding protein in the absence and presence of immunosuppressant ligands.
    Yu L; Fesik SW
    Biochim Biophys Acta; 1994 Nov; 1209(1):24-32. PubMed ID: 7524680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large-scale processing of kinetic data files with derivation of the inhibitory constant Ki: an application to proline isomerases.
    Galat A
    Comput Chem; 1996 Jun; 20(2):279-81. PubMed ID: 8936426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 as an agonist to induce inhibition of interleukin 2 production.
    Bundick RV; Donald DK; Eady RP; Hutchinson R; Keogh RW; Schmidt JA; Wells E
    Transplantation; 1992 May; 53(5):1150-3. PubMed ID: 1374947
    [No Abstract]   [Full Text] [Related]  

  • 19. Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes.
    Harrison RK; Stein RL
    Biochemistry; 1990 Apr; 29(16):3813-6. PubMed ID: 1693856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.
    Rosen MK; Standaert RF; Galat A; Nakatsuka M; Schreiber SL
    Science; 1990 May; 248(4957):863-6. PubMed ID: 1693013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.